Calamos Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852K | Buy |
12,192
+6
| +0% | +$419 | ﹤0.01% | 672 |
|
|
2025
Q1 | $896K | Buy |
12,186
+47
| +0.4% | +$3.46K | ﹤0.01% | 629 |
|
|
2024
Q4 | $795K | Buy |
12,139
+70
| +0.6% | +$4.59K | ﹤0.01% | 659 |
|
|
2024
Q3 | $940K | Hold |
12,069
| – | – | ﹤0.01% | 645 |
|
|
2024
Q2 | $941K | Sell |
12,069
-77
| -0.6% | -$6.01K | ﹤0.01% | 621 |
|
|
2024
Q1 | $823K | Buy |
+12,146
| New | +$823K | ﹤0.01% | 640 |
|
|
2021
Q4 | – | Sell |
-296,907
| Closed | -$17.8M | – | 1087 |
|
|
2021
Q3 | $17.8M | Buy |
+296,907
| New | +$17.8M | 0.08% | 264 |
|
|
2019
Q3 | – | Sell |
-74,425
| Closed | -$3.07M | – | 699 |
|
|
2019
Q2 | $3.07M | Sell |
74,425
-24,575
| -25% | -$1.01M | 0.02% | 549 |
|
|
2019
Q1 | $4M | Hold |
99,000
| – | – | 0.03% | 465 |
|
|
2018
Q4 | $3.76M | Buy |
99,000
+9,700
| +11% | +$368K | 0.02% | 460 |
|
|
2018
Q3 | $3.53M | Buy |
+89,300
| New | +$3.53M | 0.02% | 481 |
|